Insiders · INDV

Timothy C Dec

SVP, Chief Financial Officer at Supernus, Inc. (INDV) since November 2026

Timothy C Dec has filed 34 insider reports with the SEC since March 2021, as SVP and chief Financial Officer at Supernus, Inc. (INDV), senior Vice-President & CFO at Supernus Pharmaceuticals, Inc. (SUPN) and officer at Opgen Inc (OPGN). Timothy C Dec made no open-market purchases or sales in the last 12 months. The latest filing, on November 4, 2026, reports other acquisition or disposition at Supernus, Inc. (INDV).

Filings
34
Companies
3
Bought on market
None
Sold on market
$524K

Companies where Timothy C Dec is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Supernus, Inc. logo
INDV
Supernus, Inc.
SVP, Chief Financial Officersince November 202614,059$36.28Nov 4, 2026
Supernus Pharmaceuticals, Inc. logo
SUPN
Supernus Pharmaceuticals, Inc.
Senior Vice-President & CFOsince August 20210$524K$28.61Nov 4, 2026
Opgen Inc logo
OPGN
Opgen Inc
Officer1,509May 19, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Timothy C Dec.

Compare Timothy C Dec with

Other insiders at the same companies

Questions about Timothy C Dec

What is Timothy C Dec's role at Supernus, Inc.?
Timothy C Dec reports to the SEC as SVP and chief Financial Officer at Supernus, Inc. (INDV), according to the latest filing on November 4, 2026. Timothy C Dec has also filed as senior Vice-President & CFO at Supernus Pharmaceuticals, Inc. (SUPN) and officer at Opgen Inc (OPGN).
How many shares does Timothy C Dec own?
After the latest filing that states it, Timothy C Dec directly owned 14,059 shares of Supernus, Inc. (INDV) and 1,509 shares of Opgen Inc (OPGN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Timothy C Dec bought or sold stock recently?
The most recent open-market sale was on August 22, 2025: sold 11,780 shares of Supernus Pharmaceuticals, Inc. (SUPN) for $524K at an average of $44.49.
How do I get alerts when Timothy C Dec files?
Follow Timothy C Dec on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Timothy C Dec filed 4 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Timothy C Dec (SEC CIK 0001194020). Totals count each trade once, skipping amendments whose original is on file, from Mar 5, 2021 on. View on SEC EDGAR · Get this as JSON